To: Clayleas who wrote (2403 ) 6/5/1998 6:33:00 PM From: Robin Read Replies (3) | Respond to of 5736
4a. No deal or deal far below expectations. or 4b. Market makers pulling down this stock prior to announcement. Before any out there issue any vociferous responses, please understand my wish of no ill will towards any CCSI longs. I myself am long 500 shares of SPRX (small player, I admit) and the strong opinions of many on this thread cause many of us to lurk quietly on the sidelines. As for the bilirubin products, I do not believe these will be a significant portion of business for either company (SPRX or CCSI) in the long run and therefore, I feel that my interest in SPRX does not interfere with my opinion of CCSI. For SPRX, the diabetes instruments are the major products and for CCSI, the dental industry will offer a more lucrative market for their technology (as has been pointed out on this thread). In the short term, the 'bili' product provides much needed cash for CCSI and manufacturing/operational experience for SPRX. My decision to go with SPRX as opposed to CCSI has more to do with the manner and order in which SPRX has chosen to get into business (establishing relationships with med mfr's first and developing products in cooperation thereafter as well as maintaining sufficient cash reserves) and less to do with product superiority. That will come more into play as both parties have product approved and being used in the marketplace, then later, this will become less important as other products and markets are developed by each. That said, let's get on to my take on why this deal is taking so long to be announced. As has been stated by many, the negotiations are completed and the deal is done. Many of you have stated that you have spoken directly to Darby and I like you believe that, at a minimum, the structure of a deal has been cast. Now, unfortunately for this thread, many of you have a polarized position; either you believe the deal is done and it's phenomenal, or you believe there is no deal and Darby is a liar. Only a few here have looked at this from the position of a CEO working to arrange the best financial deal for her company's product while having to negotiate from a known position of financial weakness. The potential partners know this and will seek to get the best deal for themselves, not for CCSI. The fact that CCSI is still in there swinging is a testiment to Darby and shows that she is a tough competitor. But we all need to recognize and acknowledge that this deal is necessary for the short and long term health of CCSI and the longer it takes to get the announcement, the less likely this deal will be as good as you all hope. Consider the experience of buying or selling a home. If the seller needs to sell the home and the potential buyer knows it, then the buyer rushes to get the initial contract signed ('the deal is done, we just need to get the lawyers to do the final wording') and then gives the seller grief during the subsequent due diligence. The buyer aggressively looks for problems (or potential problems) partially to protect their interest and partially to get a better deal and then renegotiates each section of the contract as 'problems' or 'concerns' are identified. Meanwhile, the seller is just desperately trying to close the deal and get on with things. I personally believe that the delay in this announcement is due to this and is, for the most part, out of Darby's hands. Add to this the recent examples of Biocontrol Technologies (BICO) and Futrex (now privately held). In the early ninties, each was racing to get a non-invasive diabetes product to market. BICO is now fighting investor unrest and Futrex had to go through extensive SEC violation investigations. I say this not to suggest that CCSI would consider going down the path that either of these companies took, but rather that the investment community has already gone through unpleasant experiences regarding investments in non-invasive medical instrumentation and is probably applying some of that experience here as well. This, in addition to the delays in getting this deal announced are now being reflected in the price of this stock. My hopes are that CCSI gets this deal (I don't believe that it will be as good as many here hope) done and that financial reserves are then in place to get the dental product going. At that time (once CCSI has some continuing revenue) I will pursue an investment in CCSI. Until then, I look to SPRX to get some manufacturing and operating experience under their belt with their 'bili' product in preparation for their diabetes products. In the meanwhile, I hope that none of you take offense to any of my comments and I welcome sincere correction, if any is due. Good luck to each of you here and especially CCSI. I hope to make some money on you as soon as I feel the prospects are more defined. Good luck to each and all! Rockin' Robin